A costing study of bortezomib shows equivalence of its real‐world costs to conventional treatment. (31st January 2020) - Thompson, Jane F.; Teh, Zoe; Chen, Yiyang; Gardiner, Joanne; Bednarz, Jana M.; Thompson, Geoffrey N.; Lee, Cindy; Horvath, Noemi; Bardy, Peter; Yeung, David